Physician

Matthew Gregory Guess, M.D.

According to 2025 Medicare claims, Matthew Guess, M.D. (NPI: 1629230339) practices ophthalmology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Anchorage, AK. This provider's primary affiliated billing organization is ALASKA RETINAL CONSULTANTS (NPI: 1003934340; TIN: 920147885) and primary practice location at 99518-1641.

Guess' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,601 traditional Medicare patients, billed 77,913 HCPCS/CPT codes, and received $3,838,637 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 536 prescription claims across 147 beneficiaries totaling $25,145 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 18 records totaling $389. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $29,194 to $3,838,637. Similarly, Part D prescription costs have risen steadily, from $4,008 to $25,145. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $29,194 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $379,603 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $980,663 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,174,548 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,309,563 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,747,578 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,951,681 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,028,257 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,947,103 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,838,637 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015139223$29,194
20167212,206$379,603
20171,2065,134$980,663
20181,4036,401$1,174,548
20191,3836,637$1,309,563
20201,4488,314$1,747,578
20211,4849,339$1,951,681
20221,24512,027$2,028,257
20231,67844,279$2,947,103
20241,60177,913$3,838,637

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$42K2015 Drug cost: $4,008 (USD; Tot_Drug_Cst)2016 Drug cost: $4,194 (USD; Tot_Drug_Cst)2017 Drug cost: $20,135 (USD; Tot_Drug_Cst)2018 Drug cost: $14,293 (USD; Tot_Drug_Cst)2019 Drug cost: $20,420 (USD; Tot_Drug_Cst)2020 Drug cost: $20,212 (USD; Tot_Drug_Cst)2021 Drug cost: $36,622 (USD; Tot_Drug_Cst)2022 Drug cost: $40,569 (USD; Tot_Drug_Cst)2023 Drug cost: $41,909 (USD; Tot_Drug_Cst)2024 Drug cost: $25,145 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153163$4,008
201636103$4,194
201764226$20,135
201869229$14,293
2019109362$20,420
2020115383$20,212
2021114441$36,622
2022182740$40,569
2023168730$41,909
2024147536$25,145

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5841,954$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more316379$109
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more730979$72
92134Imaging of retina1,4353,173$34
J2777Injection, faricimab-svoa, 0.1 mg26564,388$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1684,575$6,003
Ketorolac TromethamineKetorolac Tromethamine1664,567$3,467
Brimonidine TartrateBrimonidine Tartrate291,388$2,029
Ciprofloxacin HclCiprofloxacin Hcl881,265$727
LatanoprostLatanoprost171,084$89

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$389Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Gregory Guess, M.D.?

Tedicare shows public-source Medicare data for Matthew Gregory Guess, M.D. (NPI 1629230339), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Gregory Guess, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Gregory Guess, M.D.?

Matthew Gregory Guess, M.D. is linked to ALASKA RETINAL CONSULTANTS (billing NPI 1003934340) in the available physician profile data.

Does Matthew Gregory Guess, M.D. have Open Payments data?

Matthew Gregory Guess, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.